RoukenBio

Andy Upsall is the founder and CEO of RoukenBio, a customer-centric organization focused on scientific innovation in the biotechnology sector. With a commitment to scientific excellence, RoukenBio supports early-stage drug development, offering reliable and innovative solutions tailored to client needs. Prior to founding RoukenBio in 2015, Andy Upsall co-founded BioOutsource Ltd, serving as Director of R&D until its acquisition by Sartorius Stedim Biotech in 2015, and held positions as Study Director at Covance and QC Virologist at MedImmune Vaccines. Andy’s leadership is characterized by a dedication to forming strong partnerships with respected biotech companies to advance novel therapeutics from discovery to clinical development.

Org chart

Teams

Offices